Is there an optimal MRI surveillance schedule for patients with high-grade glioma after standard-of-care-therapy?
Neuro Oncol
.
2021 May 5;23(5):711-712.
doi: 10.1093/neuonc/noab053.
Authors
Mary Jane Lim-Fat
1
,
Pejman Jabehdar Maralani
2
Affiliations
1
Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
2
Department of Medical Imaging, Sunnybrook Health Sciences Centre, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
PMID:
33674870
PMCID:
PMC8099464
DOI:
10.1093/neuonc/noab053
No abstract available
Publication types
Editorial
Comment
MeSH terms
Glioma* / diagnostic imaging
Glioma* / therapy
Humans
Magnetic Resonance Imaging